Tertatolol: Difference between revisions
m Protected "Tertatolol": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
No edit summary |
||
(5 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
{{Drugbox| | {{Drugbox | ||
|IUPAC_name = 1-(''tert''- | | Verifiedfields = changed | ||
| | | Watchedfields = changed | ||
| verifiedrevid = 408926545 | |||
| IUPAC_name = (±)-1-(''tert''-butylamino)-3-(3,4-dihydro-2''H''-thiochromen-8-yloxy)propan-2-ol | |||
| drug_name = Tertatolol | |||
<!--Clinical data--> | |||
| tradename = | |||
| Drugs.com = {{drugs.com|international|tertatolol}} | |||
| pregnancy_category = | |||
| legal_status = Rx-only | |||
| routes_of_administration = Oral | |||
<!--Pharmacokinetic data--> | |||
| bioavailability = | |||
| metabolism = | |||
| elimination_half-life = | |||
| excretion = | |||
<!--Identifiers--> | |||
| CAS_number_Ref = {{cascite|correct|??}} | |||
| CAS_number = 34784-64-0 | | CAS_number = 34784-64-0 | ||
| ATC_prefix = C07 | | ATC_prefix = C07 | ||
| ATC_suffix = | | ATC_suffix = AA16 | ||
| | | PubChem = 36920 | ||
| | | IUPHAR_ligand = 571 | ||
| | | UNII_Ref = {{fdacite|changed|FDA}} | ||
| C = 16 | H = 25 | N = 1 | O = 2 | S=1 | | UNII = 9ZO341YQXP | ||
| KEGG_Ref = {{keggcite|correct|kegg}} | |||
| KEGG = D07182 | |||
| ChEMBL_Ref = {{ebicite|changed|EBI}} | |||
| ChEMBL = 434200 | |||
<!--Chemical data--> | |||
| C=16 | H=25 | N=1 | O=2 | S=1 | |||
| molecular_weight = 295.44 g/mol | | molecular_weight = 295.44 g/mol | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
{{ | ==Overview== | ||
'''Tertatolol''' ('''Artex''', '''Artexal''', '''Prenalex''') is a [[medication]] in the class of [[beta blocker]]s, used in the treatment of [[hypertension|high blood pressure]]. It was discovered by the French pharmaceutical company [[Servier]] and is marketed in Europe.<ref name="isbn3-88763-075-0">{{cite book | author = Swiss Pharmaceutical Society | title = Index Nominum 2000: International Drug Directory (Book with CD-ROM) | publisher = Medpharm Scientific Publishers | location = Boca Raton | year = 2000 | pages = | isbn = 3-88763-075-0 | oclc = | doi = | url = http://books.google.com/books?id=5GpcTQD_L2oC&lpg=PA1002&pg=PA1002#v=onepage&q=&f=false}}</ref> | |||
Tertatolol has also been shown to act as a [[5-HT1A receptor|5-HT<sub>1A</sub> receptor]] [[receptor antagonist|antagonist]], similarly to [[pindolol]].<ref name="pmid7686633">{{cite journal | author = Jolas T, Haj-Dahmane S, Lanfumey L, ''et al.'' | title = (-)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain | journal = Naunyn-Schmiedeberg's Archives of Pharmacology | volume = 347 | issue = 5 | pages = 453–63 |date=May 1993 | pmid = 7686633 | doi = | url = }}</ref><ref name="isbn0-444-82041-8">{{cite book | author = Soudijn, W.; Olivier, Berend; Wijngaarden, I. van | title = Serotonin receptors and their ligands | publisher = Elsevier | location = Amsterdam | year = 1997 | pages = | isbn = 0-444-82041-8 | oclc = | doi = | url = http://books.google.com/books?id=lfo0hGqIex0C&lpg=PA37&pg=PA37#v=onepage&q=&f=false}}</ref> | |||
==See Also== | |||
* [[Beta blocker]] | |||
==External Links== | |||
* [http://www.servier.com/index.asp Servier official website] | |||
*[http://www.servier.com/index.asp Servier official website] | |||
==References== | |||
{{reflist|2}} | |||
{{Beta blockers}} | {{Beta blockers}} | ||
[[Category:Cardiovascular Drugs]] | |||
[[Category:Drug]] | |||
[[Category:Beta blockers]] |
Latest revision as of 02:47, 25 July 2014
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
UNII | |
KEGG | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C16H25NO2S |
Molar mass | 295.44 g/mol |
|
WikiDoc Resources for Tertatolol |
Articles |
---|
Most recent articles on Tertatolol |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Tertatolol at Clinical Trials.gov Clinical Trials on Tertatolol at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Tertatolol
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Tertatolol Discussion groups on Tertatolol Patient Handouts on Tertatolol Directions to Hospitals Treating Tertatolol Risk calculators and risk factors for Tertatolol
|
Healthcare Provider Resources |
Causes & Risk Factors for Tertatolol |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Tertatolol (Artex, Artexal, Prenalex) is a medication in the class of beta blockers, used in the treatment of high blood pressure. It was discovered by the French pharmaceutical company Servier and is marketed in Europe.[1]
Tertatolol has also been shown to act as a 5-HT1A receptor antagonist, similarly to pindolol.[2][3]
See Also
External Links
References
- ↑ Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. ISBN 3-88763-075-0.
- ↑ Jolas T, Haj-Dahmane S, Lanfumey L; et al. (May 1993). "(-)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain". Naunyn-Schmiedeberg's Archives of Pharmacology. 347 (5): 453–63. PMID 7686633.
- ↑ Soudijn, W.; Olivier, Berend; Wijngaarden, I. van (1997). Serotonin receptors and their ligands. Amsterdam: Elsevier. ISBN 0-444-82041-8.
- Pages with script errors
- CS1 maint: Explicit use of et al.
- CS1 maint: Multiple names: authors list
- Template:drugs.com link with non-standard subpage
- Drugs with non-standard legal status
- Articles with changed EBI identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Infobox drug articles with non-default infobox title
- Infobox drug articles without a structure image
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Cardiovascular Drugs
- Drug
- Beta blockers